Perspective Back to Top The current demand for weight loss medication outstrips the available supply of FDA- approved agents
In both cases, modifications made to the structures of the peptides cause their bioavailability to be increased dramatically compared to the hormones secreted naturally by the intestine, from just a few minutes to more than a hundred hours, which allows these drugs to be administered by subcutaneous injection only once a week
At JosephCareRX, we incorporate GLP-1-based medications as part of individualized treatment plans for patients struggling with obesity, type 2 diabetes, or metabolic syndrome
Shima Hadidchi, MD specialized in medical weight loss and stays current with all FDA-approved GLP-1 treatments
This slow approach reduces nausea, fatigue, and other side effects
It's $87 in France and $83 in Australia